UBS Group AG - ONCONOVA THERAPEUTICS INC ownership

ONCONOVA THERAPEUTICS INC's ticker is ONTX and the CUSIP is 68232V801. A total of 29 filers reported holding ONCONOVA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45
-99.3%
63
-98.9%
0.00%
Q2 2023$6,673
-37.5%
5,655
-61.3%
0.00%
Q1 2023$10,669
+13.4%
14,595
+0.9%
0.00%
Q4 2022$9,406
-53.0%
14,471
-38.4%
0.00%
Q3 2022$20,00023,504
+7734.7%
0.00%
Q2 2022$0
-100.0%
300
-92.7%
0.00%
Q1 2022$7,000
+16.7%
4,119
+69.4%
0.00%
Q4 2021$6,000
-62.5%
2,432
-40.2%
0.00%
Q3 2021$16,000
-40.7%
4,064
+3.4%
0.00%
Q2 2021$27,0003,9300.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Hillcrest Wealth Advisors - NY, LLC 16,723$22,0000.01%
EMFO, LLC 3,333$4,0000.00%
TWO SIGMA ADVISERS, LP 178,912$236,0000.00%
Renaissance Technologies 333,323$440,0000.00%
Beacon Pointe Advisors, LLC 51,976$68,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 33$00.00%
Glassman Wealth Services 133$00.00%
OSAIC HOLDINGS, INC. 10$00.00%
Parallel Advisors, LLC 13$00.00%
BANK OF AMERICA CORP /DE/ 33$00.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders